Table 6

Resection limit status in the untreated and treated patients with clinical stage B disease

Surgery only (%)12 weeks of NHT (%)24 weeks of NHT (%)
Chi square=18.953; p<0.001. Untreated versus 12 weeks of NHT: χ2=8.613; p=0.003. Untreated versus 24 weeks of NHT: χ2=15.284; p<0.001. 12 weeks of NHT versus 24 weeks of NHT: χ2=1.096; p=0.295 (not significant).
NHT, neoadjuvant hormonal treatment.
Negative margins53 (53.5%)80 (74.1%)74 (81.3%)
Positive margins46 (46.5%)28 (25.9%)17 (18.7%)